 |
4-amino-1-[(1S,4R,5S)-2-fluoro-4,5-dihydroxy-3-(hydroxymethyl) cyclopent-2-en-1-yl] pyrimidin-2-one |
|---|---|
| Trade Name | |
| Orphan Indication | Pancreatic cancer |
| USA Market Approval | USA |
| USA Designation Date | 2014-09-23 00:00:00 |
| Sponsor | Rexahn Pharmaceuticals, Inc.;15245 Shady Grove Road;Rockville, Maryland, 20850 |
